Timing optimization of teriparatide dosing for postmenopausal osteoporosis: a randomized controlled trial
Abstract Background Accumulating evidence highlights the critical role of circadian rhythms in regulating bone turnover. Bone turnover markers, including parathyroid hormone, C-terminal telopeptide of type I collagen, and N-terminal propeptide of type I procollagen, all exhibit distinct diurnal vari...
Saved in:
| Main Authors: | Huan Wang, Liyuan Tao, Dongyang Liu, Xiaoyan Yan, Haiyan Li, Chunli Song |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Journal of Orthopaedic Surgery and Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13018-025-06083-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Phase 3 Multicenter, Double‐Blind Study Comparing Efficacy, Safety, Immunogenicity, and Pharmacokinetics of Alkem's Biosimilar Teriparatide Versus Reference Teriparatide in Postmenopausal Osteoporosis
by: Nitin Kapoor, et al.
Published: (2025-06-01) -
Comparative efficacy of teriparatide and bisphosphonates or denosumab vs. teriparatide monotherapy in osteoporosis: a meta-analysis
by: Huan Jin, et al.
Published: (2025-05-01) -
Efficacy and safety of narlumosbart, an anti-RANKL monoclonal antibody, in postmenopausal women with osteoporosis: a multi-center, randomized, double-blind, placebo- and active-controlled, phased II studyResearch in context
by: Yue Chi, et al.
Published: (2025-07-01) -
Combination or sequential teriparatide for osteoporosis treatment in denosumab-users: real-world bone mineral density outcomes
by: Shejil KUMAR, et al.
Published: (2025-06-01) -
Multiple Myeloma Case Developed During the Use of the Teriparatide
by: Zehra Erdemir, et al.
Published: (2022-04-01)